← Open Payments lookup

MARSHALL WIGFALL: Open Payments

NPI 1629306139 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$770 in 32 payments from 5 companies in 2025. Trend: 2023 $284 · 2024 $527 · 2025 $770

Food & beverage: $770
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$340
Otsuka America Pharmaceutical, Inc.7$246
Vanda Pharmaceuticals Inc.11$146
E.R. Squibb & Sons, L.L.C.1$24
Teva Pharmaceuticals USA, Inc.1$14

Products named: CAPLYTA, REXULTI, FANAPT, ABILIFY ASIMTUFII, HETLIOZ, COBENFY, UZEDY, ABILIFY MAINTENA.

Industry payments across VA — which companies pay providers there.